glp-1 side effects blindness Ozempic LEAD TO BLINDNESS?! NAION and GLP1s: Rare Cause
Description
Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers
[DOI] [PubMed] [Google Scholar] 18
In comparison, no PK study indicated that the use of SGLT2 inhibitors could impact the required dose of levothyroxine to treat hypothyroidism
Through microdosing, these benefits can be tailored to individual needs, providing an opportunity for personalized, root-cause-focused care
Holly Wyatt, profesora adjunta asociada en Medicina en la Universidad de Colorado Anschutz
